Stroke

• 

  Publication Venue For

  • Research Opportunities in Stroke Prevention for Atrial Fibrillation: A Report From a National Heart, Lung, and Blood Institute Virtual Workshop..  54:e75-e85. 2023
  • Recurrent Ischemic Stroke and Bleeding in Patients With Atrial Fibrillation Who Suffered an Acute Stroke While on Treatment With Nonvitamin K Antagonist Oral Anticoagulants: The RENO-EXTEND Study..  53:2620-2627. 2022
  • Outcomes of Endovascular Therapy in Patients With Prestroke Mobility Impairment.  52. 2021
  • Letter by Moris et al Regarding Article, "One-Year Outcomes After Minor Stroke or High-Risk Transient Ischemic Attack: Korean Multicenter Stroke Registry Analysis"..  49:e129. 2018
  • Letter by Moris et al Regarding Article, "Ticagrelor in Acute Stroke or Transient Ischemic Attack in Asian Patients: From the SOCRATES Trial (Acute Stroke or Transient Ischemic Attack Treated With Aspirin or Ticagrelor and Patient Outcomes)"..  48:e110. 2017
  • Letter by Moris and Avgerinos Regarding Article, "Long-Term Outcome After Carotid Artery Stenting: A Population-Based Matched Cohort Study"..  47:e271. 2016
  • Letter by Moris and Avgerinos Regarding Article, "Recurrent Ischemic Lesions After Acute Atherothrombotic Stroke: Clopidogrel Plus Aspirin Versus Aspirin Alone"..  47:e270. 2016
  • Erratum: Endovascular thrombectomy for anterior circulation stroke: Systematic review and meta-analysis (Stroke. 2015 46 (3177-3183)).  46:e249. 2015
  • Response to Letter by Makris et al regarding article, carotid artery stenting versus carotid endarterectomy: A comprehensive meta-analysis of short-term and long-term outcomes.  42. 2011
  • Response to letter by Antonopoulos et al regarding article, carotid artery stenting versus carotid endarterectomy: A comprehensive meta-analysis of short-term and long-term outcomes.  42. 2011
  • Carotid artery stenting versus carotid endarterectomy: a comprehensive meta-analysis of short-term and long-term outcomes..  42:687-692. 2011
  • Genetic Variation in LPAL2 , LPA , and PLG Predicts Plasma Lipoprotein(a) Level and Carotid Artery Disease Risk.  42:2-9. 2011
  • Response to letter by Martínez-Sánchez et al.  41. 2010
  • Trends in survival and recovery from stroke: evidence from the National Long-Term Care Survey/Medicare data..  41:563-565. 2010
  • Response to letter by bray and bladin.  40. 2009
  • Hypoxic Preconditioning Stimulates Mitochondrial Biogenesis and Promotes Brain Ischemic Tolerance by Akt Pathway Activation.  40:E139-E139. 2009
  • Response to letter by Mascitelli et al.  39. 2008
  • Erratum: National Institute of Neurological Disorders and Stroke-Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards (Stroke (2006) 37, 9, (2220-2241)).  38:1118. 2007
  • Response to letter by Hart [5].  37:1966. 2006
  • Response to letter by Mysak et al [7].  37:1968. 2006
  • Increasing rates of dementia at time of declining mortality from stroke..  37:1155-1159. 2006
  • Comparative overview of brain perfusion imaging techniques.  36:2032-2033. 2005
  • Panel of serum markers for rapid diagnosis of acute stroke - Response.  35:E140-E141. 2004
  • Re: Feasibility and safety of moderate hypothermia after massive hemispheric infarction - Response.  33:877-878. 2002
  • Attenuation of cerebral vasospasm following subarachnoid hemorrhage in mice over-expressing extracellular superoxide dismutase.  33:380-380. 2002
  • The next generation: The need to expand upon traditional risk factors for stroke - Editorial comment.  33:236-237. 2002
  • Erratum: Effect of apolipoprotein E genotype on cerebral autoregulation during cardiopulmonary bypass (Store (July 2000) 32:7 (1514-1519)).  32:2727. 2001
  • Coagulopathies in ischemic stroke [3] (multiple letters).  32:1235. 2001
  • Health-related quality of life after stroke: A comprehensive review.  32:972. 2001
  • Adherence to post-acute rehabilitation guidelines improves functional recovery in stroke.  32:333-333. 2001
  • Anticoagulation for atrial fibrillation: Physicians' readiness to change practices.  32:333-333. 2001
  • Effects of extracellular superoxide dismutase on arterial vascular structural changes after acute subarachnoid hemorrhage in the mouse.  32:359-359. 2001
  • Have randomized controlled trials of neuroprotective drugs been underpowered?: An illustration of three statistical principles.  32:373-373. 2001
  • Abciximab in acute ischemic stroke. A randomized, double-blind, placebo-controlled, dose-escalation study..  31:601-609. 2000
  • Racial variation in initial stroke severity..  31:563-567. 2000
  • Multicenter study of poststroke neurorehabilitation: Implications for trial design - Burke SRCI group.  31:303-303. 2000
  • Non-hospitalized TLA and stroke: Management by primary care physicians.  31:311-311. 2000
  • North Carolina stroke prevention and treatment facilities survey. Statewide availability of programs and services..  31:66-70. 2000
  • The incidence and occurrence of total (first-ever and recurrent) stroke.  31:283-283. 2000
  • Use of coagulation tests in the evaluation of acute ischemic stroke.  31:332-332. 2000
  • Diffusion MR imaging and transient ischemic attacks [4] (multiple letters).  30:2762-2763. 1999
  • Diffusion MR imaging and transient ischemic attacks..  30:2762-2763. 1999
  • Incidence and occurrence of total (first-ever and recurrent) stroke..  30:2523-2528. 1999
  • Inhibition of rat vascular smooth muscle cell proliferation in vitro and in vivo by recombinant replication-competent herpes simplex virus - Editorial Comment.  30:2438-2439. 1999
  • Racial inequity of access to carotid imaging..  30:2491. 1999
  • Cerebrovascular disease and depression symptoms in the cardiovascular health study..  30:2159-2166. 1999
  • Preventing ischemic stroke in patients with prior stroke and transient ischemic attack : a statement for healthcare professionals from the Stroke Council of the American Heart Association..  30:1991-1994. 1999
  • Race, presenting signs and symptoms, use of carotid artery imaging, and appropriateness of carotid endarterectomy..  30:1350-1356. 1999
  • Clinical stroke trials: guarding against bias..  30:1165-1166. 1999
  • Progression of mass effect after intracerebral hemorrhage..  30:1167-1173. 1999
  • Apolipoprotein E deficiency worsens outcome from global cerebral ischemia in the mouse..  30:1118-1124. 1999
  • Compensatory mechanisms for chronic cerebral hypoperfusion in patients with carotid occlusion..  30:1019-1024. 1999
  • Lack of correlation between pattern of collateralization and misery perfusion in patients with carotid occlusion..  30:1025-1032. 1999
  • Amphetamine-facilitated poststroke recovery..  30:696-698. 1999
  • Cerebral injury after cardiac surgery: identification of a group at extraordinary risk. Multicenter Study of Perioperative Ischemia Research Group (McSPI) and the Ischemia Research Education Foundation (IREF) Investigators..  30:514-522. 1999
  • Poststroke pruritus..  30:692-693. 1999
  • Epidemiology of recurrent cerebral infarction: a medicare claims-based comparison of first and recurrent strokes on 2-year survival and cost..  30:338-349. 1999
  • Adenovirus-mediated gene transfer is augmented in basilar and carotid arteries of heritable hyperlipidemic rabbits - Comment.  30:125-125. 1999
  • Signal intensity of exponential diffusion weighted images correlates with infarct age.  30:260-260. 1999
  • Stroke-related knowledge among patients with access to medical care in the stroke belt.  30:253-253. 1999
  • North Carolina stroke prevention and treatment facilities survey: rtPA therapy for acute stroke..  29:2069-2072. 1998
  • Comparison of the ABC/2 estimation technique to computer-assisted volumetric analysis of intraparenchymal and subdural hematomas complicating the GUSTO-1 trial..  29:1799-1801. 1998
  • Depressed platelet status in an elderly patient with hemorrhagic stroke after thrombolysis for acute myocardial infarction..  29:2002-2003. 1998
  • Accuracy of ICD-9-CM coding for the identification of patients with acute ischemic stroke: effect of modifier codes..  29:1602-1604. 1998
  • Effects of a synthetic allosteric modifier of hemoglobin oxygen affinity on outcome from global cerebral ischemia in the rat..  29:1650-1655. 1998
  • Expression of nerve growth factor and trkA after transient focal cerebral ischemia in rats - Comment.  29:1697-1697. 1998
  • Concerns regarding carotid endarterectomy guidelines..  29:1475-1476. 1998
  • Increased oxygen extraction fraction is associated with prior ischemic events in patients with carotid occlusion..  29:754-758. 1998
  • Multicenter review of preoperative risk factors for endarterectomy for asymptomatic carotid artery stenosis..  29:750-753. 1998
  • The Working Group report on Science-Based Categories for Abstracts: submitted to the annual scientific sessions. The Committee on Scientific Sessions Program (CSSP), American Heart Association..  29:881-884. 1998
  • Neuroanatomic localization of magnetic resonance imaging signal hyperintensities in geriatric depression..  29:613-617. 1998
  • Thrombolysis-related intracranial hemorrhage: a radiographic analysis of 244 cases from the GUSTO-1 trial with clinical correlation. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries..  29:563-569. 1998
  • Guidelines for carotid endarterectomy: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association..  29:554-562. 1998
  • Concerns regarding carotid endarterectomy guidelines - Response.  29:1475-1476. 1998
  • Depressed platelet status in an elderly patient with hemorrhagic stroke after thrombolysis for acute myocardial infarction. GUSTO-III Investigators..  29:235-238. 1998
  • Genetic studies of intracerebral hemorrhage.  29:320-320. 1998
  • American Heart Association Prevention Conference. IV. Prevention and Rehabilitation of Stroke. Risk factors..  28:1507-1517. 1997
  • Retrospective assessment of initial stroke severity with the Canadian Neurological Scale..  28:1181-1184. 1997
  • Complication rates for carotid endarterectomy. A call to action..  28:889-890. 1997
  • Knowledge of risk among patients at increased risk for stroke..  28:916-921. 1997
  • Health status of individuals with mild stroke..  28:740-745. 1997
  • Hospitalization and case-fatality rates for subarachnoid hemorrhage in Canada from 1982 through 1991. The Canadian Collaborative Study Group of Stroke Hospitalizations..  28:793-798. 1997
  • Primary care physician-reported secondary and tertiary stroke prevention practices. A comparison between the United States and the United Kingdom..  28:746-751. 1997
  • Intravenous basic fibroblast growth factor decreases brain injury resulting from focal ischemia in cats - Comment.  28:615-616. 1997
  • Subdural hematoma and lupus anticoagulants..  28:646-648. 1997
  • Reliability of the National Institutes of Health Stroke Scale. Extension to non-neurologists in the context of a clinical trial..  28:307-310. 1997
  • Editorial.  28:1657-. 1997
  • Extension of the reliability of the NIH stroke, scale to non-neurologists.  28:23-23. 1997
  • Incidence of stroke may be on the rise..  28:1657-1659. 1997
  • Polymorphism in endoglin as a risk factor for intracerebral hemorrhage.  28:69-69. 1997
  • Racial differences in the utilization of inpatient rehabilitation services among elderly stroke patients..  28:19-25. 1997
  • Cost-effectiveness of screening for asymptomatic carotid atherosclerotic disease..  27:1944-1950. 1996
  • What role do neurologists play in determining the costs and outcomes of stroke patients?.  27:1937-1943. 1996
  • US National Survey of Physician Practices for the Secondary and Tertiary Prevention of Ischemic Stroke. Medical therapy in patients with carotid artery stenosis..  27:1473-1478. 1996
  • Acute changes in intracranial pressure and pressure-volume index after forebrain ischemia in normoglycemic and hyperglycemic rats..  27:1405-1409. 1996
  • Apolipoprotein E polymorphism and stroke in a population sample aged 75 years or more..  27:1310-1315. 1996
  • Hospitalization and case-fatality rates for stroke in Canada from 1982 through 1991. The Canadian Collaborative Study Group of Stroke Hospitalizations..  27:1215-1220. 1996
  • US National Survey of Physician Practices for the Secondary and Tertiary Prevention of Ischemic Stroke. Carotid endarterectomy..  27:801-806. 1996
  • Mitochondrial generation of reactive oxygen species after brain ischemia in the rat..  27:327-331. 1996
  • Clinical and radiographic factors associated with mortality following intracranial hemorrhage after thrombolysis for acute myocardial infarction.  27:90-90. 1996
  • Effect of ApoE genotype and age on survival after intracerebral hemorrhage.  27:94-94. 1996
  • National survey of stroke prevention practices: Surgical management.  27:32-32. 1996
  • Cystatin C mutation in an elderly man with sporadic amyloid angiopathy and intracerebral hemorrhage..  26:2190-2193. 1995
  • Stroke in young black patients. Risk factors, subtypes, and prognosis..  26:1995-1998. 1995
  • US national survey of physician practices for the secondary and tertiary prevention of ischemic stroke. Design, service availability, and common practices..  26:1607-1615. 1995
  • Ipsilateral internal carotid artery redissection on anticoagulation..  26:1302-1303. 1995
  • Fatal infantile polyarteritis nodosa with predominant central nervous system involvement..  26:699-701. 1995
  • MACROVASCULAR AND MICROVASCULAR ASSESSMENT OF ACUTE STROKE USING TCD AND GADOLINIUM-DTPA MR PERFUSION IMAGING - A COMPARATIVE-STUDY.  26:729-729. 1995
  • Safety and tolerability of the glutamate antagonist CGS 19755 (Selfotel) in patients with acute ischemic stroke. Results of a phase IIa randomized trial..  26:602-605. 1995
  • Stroke due to recurrent ipsilateral carotid artery dissection in a young adult..  26:480-483. 1995
  • Nitric oxide synthase inhibition and extracellular glutamate concentration after cerebral ischemia/reperfusion..  26:298-304. 1995
  • Guidelines for carotid endarterectomy. A multidisciplinary consensus statement from the ad hoc Committee, American Heart Association..  26:188-201. 1995
  • IDENTIFICATION OF PERFUSION PENUMBRA IN ACUTE MIDDLE CEREBRAL ARTERIAL STROKE BY GADOLINIUM-DTPA MRI.  26:180-180. 1995
  • Response: Ipsilateral internal carotid artery redissection on anticoagulation.  26:1303. 1995
  • US NATIONAL SURVEY OF PHYSICIAN PRACTICES FOR STROKE PREVENTION.  26:161-161. 1995
  • Background factors and clinical symptoms of major depression with silent cerebral infarction..  25:2507. 1994
  • PREOPERATIVE RISK-FACTORS FOR CAROTID ENDARTERECTOMY - REPLY.  25:2097-2097. 1994
  • Preoperative risk factors for carotid endarterectomy..  25:2096-2097. 1994
  • Sample size calculations for clinical trials using the NIH Stroke Scale..  25:1700-1701. 1994
  • The importance of family history in cerebrovascular disease..  25:1599-1604. 1994
  • Ganglioside GM1 in acute ischemic stroke. The SASS Trial..  25:1141-1148. 1994
  • Multicenter review of preoperative risk factors for carotid endarterectomy in patients with ipsilateral symptoms..  25:1116-1121. 1994
  • Similar motor recovery of upper and lower extremities after stroke..  25:1181-1188. 1994
  • GENETIC-ASPECTS OF INTRACRANIAL ANEURYSMS AND SAH.  25:257-257. 1994
  • MULTICENTER REVIEW OF PREOPERATIVE RISK-FACTORS FOR CAROTID ENDARTERECTOMY (CEA) IN PATIENTS WITH IPSILATERAL SYMPTOMS.  25:273-273. 1994
  • RISK OF INTRACRANIAL ANEURYSMS IN FAMILIES WITH SUBARACHNOID HEMORRHAGE.  25:248-248. 1994
  • Response.  25:2097. 1994
  • Cerebral blood flow and metabolism in newborn infants. What can they teach us about stroke?.  24:I33-I34. 1993
  • The Stroke Prevention Patient Outcomes Research Team. Goals and methods..  24:2135-2142. 1993
  • Predicting complications of carotid endarterectomy..  24:1285-1291. 1993
  • Restriction fragment length polymorphism of the apoprotein A-I-C-III gene cluster in control and stroke-prone white and black subjects: racial differences..  24:909-910. 1993
  • Impact of social support on outcome in first stroke..  24:64-70. 1993
  • Measurement of motor recovery after stroke. Outcome assessment and sample size requirements..  23:1084-1089. 1992
  • Early recurrent ischemic stroke. A case-control study..  23:1010-1013. 1992
  • Mechanism of detection of acute cerebral ischemia in rats by diffusion-weighted magnetic resonance microscopy..  23:746-754. 1992
  • Stroke with negative brain magnetic resonance imaging..  23:663-667. 1992
  • Racial variations in ischemic stroke-related physical and functional impairments..  22:1497-1501. 1991
  • Recurrent transient ischemic attacks and stroke associated with an internal carotid artery web..  22:956. 1991
  • Inadequate antidiuretic hormone secretion after sagittal sinus thrombosis caused by protein S deficiency..  22:819. 1991
  • Quantitative proton magnetic resonance imaging in focal cerebral ischemia in rat brain..  22:259-268. 1991
  • Recurrent transient ischemic attacks and stroke associated with an internal carotid artery web: To the editor.  22:956. 1991
  • Recurrent transient ischemic attacks and stroke in association with an internal carotid artery web..  22:94-98. 1991
  • Cerebrospinal fluid atrial natriuretic factor in intracranial disease..  21:1550-1554. 1990
  • Pharmacology of recovery after stroke..  21:III139-III142. 1990
  • Postischemic synaptic excitation and N-methyl-D-aspartate receptor activation in gerbils..  21:III23-III27. 1990
  • Restorative neurology. Drugs and recovery following stroke..  21:1636-1640. 1990
  • Large-dose infusions of heparinoid ORG 10172 in ischemic stroke..  21:1289-1292. 1990
  • DRUGS INFLUENCE THE RECOVERY OF FUNCTION AFTER STROKE.  21:179-179. 1990
  • Moyamoya disease associated with polycystic kidney disease and eosinophilic granuloma..  20:1092-1094. 1989
  • Comparison of [125I]HIPDm and [125I]iodoantipyrine in quantifying regional cerebral blood flow in rats..  19:1404-1410. 1988
  • Treatment of sagittal sinus thrombosis associated with cerebral hemorrhage and intracranial hypertension..  19:903-909. 1988
  • Atrial septal aneurysm: association with cerebrovascular and peripheral embolic events..  18:856-862. 1987
  • Should lumbar puncture be part of the routine evaluation of patients with cerebral ischemia?.  17:332-333. 1986
  • Positron emission tomography and its application to the study of cerebrovascular disease in man..  16:361-376. 1985
  • Should lumbar puncture be part of the routine evaluation of patients with cerebral ischemia?.  16:737. 1985
  • CVD mortality, 1968-1978: observations and implications..  15:451-457. 1984
  • Cranial nerve paralysis following carotid endarterectomy..  15:157-159. 1984
  • REGULATION OF BLOOD-FLOW IN EXPERIMENTAL BRAIN-TUMORS.  15:193-193. 1984
  • Unilateral neurogenic pruritus following stroke..  15:901-903. 1984
  • Adrenergic receptors of small cerebral blood vessels.  10:491. 1979
  • Real time ultrasound tomography of the adult brain..  9:117-122. 1978
  • Geographic differences in mortality from stroke in North Caroline. 1. Analysis of death certificates..  7:41-45. 1976
  • Regional cerebral blood flow estimated by 133-xenon inhalation..  6:245-256. 1975
  • Abstract 116: Unmet Need In Acute Ischemic Stroke Patients Not Treated With Alteplase 2022
  • Abstract 155: Hyperglycemia And Hypertension Predict Subsequent Ischemic Stroke In Patients With Minor Stroke Or TIA Treated With Dual Antiplatelet Therapy: A Post-hoc Analysis Of The POINT Trial 2022
  • Abstract 159: Recurrent Ischemic Stroke And Cigarette Smoking: A Secondary Analysis Of The POINT Trial 2022
  • Abstract 35: Unmet Need In Acute Ischemic Stroke Patients Arriving After 4.5 Hours 2022
  • Abstract TMP74: Direct Oral Anticoagulants Vs. Vitamin K Antagonists In Patients With Cerebral Venous Thrombosis: A Systematic Review And Meta-analysis 2022
  • Abstract TMP77: Borderzone Infarction Predicts Recurrence In Patients With Intracranial Atherosclerosis: A Meta-analysis 2022
  • Abstract TP133: Diabetes/hyperglycemia Is Associated With Poor Six-month Functional Outcomes, But Is Not Associated With The Development Of Microvascular Ischemic Lesions After Intracerebral Hemorrhage 2022
  • Abstract TP227: High Disability Rates In Young Patients With PFO Attributable Cryptogenic Ischemic Strokes 2022
  • Abstract TP96: Mild Luminal Stenosis Of Parent Artery And Neurologic Deterioration After Acute Lacunar Stroke 2022
  • Abstract 31: Penumbra Consumption Rates Based on T Max Delay and Reperfusion Status: A Post-Hoc Analysis of the Defuse-3 Trial 2021
  • Abstract 59: Presence of Infarct Predicts Recurrence and Efficacy of Dual Antiplatelet Therapy: A Post-Hoc Analysis of the POINT Trial 2021
  • Abstract MP46: Internal Carotid Artery Web and Acute Ischemic Stroke - A Systematic Review and Meta-Analysis 2021
  • Abstract P100: Hemorrhagic Stroke in the Setting of COVID-19 is Associated With Anticoagulation Use 2021
  • Abstract P102: Elevated Von Willebrand Factor in Patients Presenting With Large-Vessel Occlusion Stroke as First Symptom of COVID-19 Mirrors Levels in Patients With COVID-19 Requiring ICU-Level Care 2021
  • Abstract P10: Posterior Circulation Strokes Are Less Likely to Receive Alteplase or Mechanical Thrombectomy: Analysis From the IAC Study 2021
  • Abstract P12: Alteplase Reduces Mortality in Patients With Ischemic Stroke and Atrial Fibrillation: Analysis of the IAC Study 2021
  • Abstract P180: Protocolized Selection for Telestroke Activation in The Extended Window for Thrombectomy 2021
  • Abstract P227: Incentives for Uptake and Adherence With Outpatient Stroke Rehabilitation: A Three Arm Randomized Controlled Trial 2021
  • Abstract P252: Discharge Antithrombotic Therapy for Ischemic Stroke Patients With Prior Aspirin Failure 2021
  • Abstract P254: Decompressive Hemicraniectomy and Functional Outcomes After Malignant Cerebral Infarction: Real World Experience From a Comprehensive Stroke Center 2021
  • Abstract P27: Safety and Efficacy of Alteplase in Ischemic Stroke Patients > 80 Years of Age in the Extended Time Window 2021
  • Abstract P387: Stroke Despite Anticoagulation Therapy Predicts Early Recurrence After Cardioembolic Stroke: The IAC-Study 2021
  • Abstract P438: A Reassessment of Hemoglobin and Hematoma Expansion in Intracerebral Hemorrhage 2021
  • Abstract P527: Temporal Trend of Mechanical Thrombectomy Utilization in Treatment of Perioperative Ischemic Stroke Following Elective Inpatient Surgery in the United States 2021
  • Abstract P592: Admission Hyperglycemia is Associated With Subsequent Ischemic Stroke After Transient Ischemic Attack or Minor Stroke: A Secondary Analysis of the POINT Trial 2021
  • Abstract P649: Extracranial Hemorrhage in the Setting of Gastrointestinal Or Genitourinary Cancer is Associated With Increased Risk of Ischemic Stroke in Patients With Atrial Fibrillation 2021
  • Abstract P661: Atheromatous Disease of the Parent Artery is Common in Patients With Lacunar Infarcts 2021
  • Abstract P674: Markers of Atherosclerotic Disease but Not Small Vessel Disease Predict Neurologic Deterioration in Acute Lacunar Strokes 2021
  • Abstract P677: Ischemic Stroke, Depressed Ejection Fraction, and Sinus Rhythm: Prevalence, Practice Patterns, and Outcomes 2021
  • Abstract P67: Role of Genetic Variants in Predicting Cognitive Outcomes Following Small Vessel Ischemic Stroke 2021
  • Aging-Related Impairment in Post-Ischemic O-GlcNAcylation Activation Critically Contributes to Stroke Outcome 2020
  • Contemporary Use of IV Alteplase in Acute Ischemic Stroke Beyond 4.5 Hours of Stroke Onset in Clinical Practice is Rare 2020
  • Impact of Medicare Reform on Inpatient Rehabilitation Facility Access for Hemorrhagic Stroke Patients 2020
  • Intravenous Thrombolysis for In-Hospital Ischemic Stroke in the Endovascular Era: Findings From the National Get With the Guidelines-Stroke Registry 2020
  • Patient Characteristics, Quality and Outcomes After Endovascular Therapy for In-Hospital Ischemic Stroke 2020
  • Trends in Dual Antiplatelet Therapy Prescription Patterns for Secondary Prevention in Patients With Noncardioembolic Ischemic Stroke 2020
  • Use, Characteristics, and Outcomes of Endovascular Thrombectomy in Acute Ischemic Stroke Patients Beyond 6 Hours of Stroke Onset in US Clinical Practice 2020
  • Association Between Medicare Reform and Access to Rehabilitation in Ischemic Stroke Patients. 2019
  • Design of the BP-COG Study of Blood Pressure Over the Life Course and Later-Life Cognition in Blacks, Hispanics, and Whites: A Pooled Cohort Analysis of ARIC, CARDIA, CHS, FOS, MESA, and NOMAS. 2019
  • Discharge Planning for Stroke Survivors in the Northeast 2019
  • Factors Associated With Patient-Reported Shared Decision-Making for Stroke Prevention in Atrial Fibrillation 2019
  • International Comparison of Patient Characteristics and Quality of Care for Ischemic Stroke 2019
  • Low Socioeconomic Status and Longer Home-to-Hospital Distances Are Associated With Less Timely Treatment of Ischemic Stroke 2019
  • Novel and Known Genes Elucidated in Cerebral Cavernous Malformation Through Comparative Transcriptomic Analysis of Multiple Model Species and Human Microdissected Lesional Endothelial Cells 2019
  • Predictors of Poor Outcome After Intracerebral Hemorrhage: Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH) Study 2019
  • Reasons Pre-Existing Mild Cognitive Impairment May Influence Physician Recommendations for Stroke and Heart Attack Treatments 2019
  • Safety and Outcomes of Intravenous Tissue Plasminogen Activator in Acute Ischemic Stroke Patients With Recent Stroke: Findings From Get With the Guidelines-Stroke 2019
  • Time to Treatment With Endovascular Reperfusion Therapy and Outcome From Acute Ischemic Stroke in the National US GWTG-Stroke Population 2019
  • Transition of Care Needs of Stroke Patients Discharged From the Hospital. 2019
  • Use of Intravenous Tissue Plasminogen Activator in Patients With History of Prior Stroke Plus Diabetes Mellitus 2019
  • Deep Learning for Acute Ischemic Stroke on Diffusion MRI: Performance Analysis in a Consecutive Cohort. 2019
  • Hospital Factors Associated With Interhospital Stroke Transfer Destination in the Northeast United States 2019
  • Interpretable Deep Learning-based Characterization of Intracranial Hemorrhage on Head CT 2019
  • An International Survey of Progressive Stroke System Processes 2018
  • Clinical Care and Outcomes of Asian Acute Ischemic Stroke Patients 2018
  • Comparison of Genetic Ancestry versus Self-Identified Race and Ethnicity as Risk Factor for Intracerebral Hemorrhage 2018
  • Disparities in Post-Acute Stroke Rehabilitation Services Delivery: Preliminary Findings From the COMprehensive Post-Acute Stroke Services (COMPASS) Study 2018
  • Impact of Concomitant Use of Antiplatelet and Anticoagulation Therapies on Outcomes in Patients With Intracerebral Hemorrhage 2018
  • Increasing Interfacility Transfers Among Northeastern Hospitals in the Care of Stroke Patients 2018
  • Longitudinal Outcomes of Medicare Beneficiaries With Transient Ischemic Attack: a GWTG-Stroke Study 2018
  • Patterns of Discharge Antidepressant Therapy Use After Acute Ischemic Stroke: Insights From the Prosper Study 2018
  • Racial Variation in Comfort Measures Only Status in Patients With Intracerebral Hemorrhage 2018
  • Rehabilitation Provider Type Influences Functional Outcome and Survival of Acute Ischemic Stroke Patients With Severe Neurological Deficits: Findings From the China National Stroke Registry II 2018
  • Intravenous Recombinant Tissue-type Plasminogen Activator Use in Young Adults With Acute Ischemic Stroke 2017
  • Seasonal Patterns of Ischemic Stroke in the United States 2017
  • Advancing Stroke Recovery Through Social and Emotional Support 2017
  • Correlation of NIH Stroke Scale and Fugl-Meyer Motor Scales in a Longitudinal Stroke Recovery Study: Implication for Feasibility Survey for Stroke Rehabilitation Trial 2017
  • Door-to-puncture and First Pass Times for Endovascular Thrombectomy: Predictors and Changes Over Time in GWTG-stroke 2017
  • Integrating Stroke Center Quality Metrics Into Pre-hospital Triage in Acute Ischemic Stroke 2017
  • Lower Hemoglobin A1c is Associated With Higher In-Hospital Mortality in Intracerebral Hemorrhage 2017
  • Quality of Care and Outcomes for Acute Ischemic Stroke Patients Admitted During the International Stroke Conference 2017
  • Reasons for Slower Door-to-Needle Times and Their Impact on Timing of Treatment and Outcomes: Findings From Get With The Guidelines-Stroke 2017
  • The Association of Prior Use of Antiplatelet Agents and Increased Mortality and Morbidity in Intracerebral Hemorrhage Patients 2017
  • Therapeutic Human Umbilical Cord Blood Cells in Ischemic Stroke 2017
  • Transitional Care in Stroke Certified and Non-certified Hospitals: The Comprehensive Post-Acute Stroke Services (COMPASS) Study 2017
  • Age Related Variations in Improvement in Door-to-Needle Times in Acute Ischemic Stroke: Findings From Target: Stroke Phase I 2016
  • Assessment and Provision of Rehabilitation Among Acute Ischemic Stroke Patients Hospitalized in China: Findings From the China National Stroke Registry II 2016
  • Assessment of Home Time Following Acute Ischemic Stroke in Medicare Beneficiaries 2016
  • Characteristics and Outcomes Among Patients Transferred to Regional Stroke Centers Across the United States for Specialized Stroke Care 2016
  • Current Use of Strategies to Improve Door-to-Needle Times With Tissue Plasminogen Activator in Acute Ischemic Stroke: Findings From the Target: Stroke Phase II Survey 2016
  • Disability, Quality of Life and Institutionalization After Inpatient Rehabilitation and Skilled Nursing Facility Care for Ischemic Stroke Patients 2016
  • Do Women Receive Less Aggressive Care Following Intracerebral Hemorrhage?. 2016
  • Effect of Idarucizumab on Intracranial Bleeding in Dabigatran-treated Patients: Initial Results From REVERSE AD. 2016
  • Equitable Improvements in Sex and Race/Ethnic Specific Door-to-Needle Times in Acute Ischemic Stroke: Findings From Target: Stroke Phase 1 2016
  • Healthcare Transitions, Service Use, and Home-time Among Stroke Survivors With Depression 2016
  • Improving Door-to-Needle Times in Acute Ischemic Stroke: Interim Fundings From Target: Stroke Phase II 2016
  • International Comparison of Patient Characteristics and Performance Measures in Acute Ischemic Stroke: Analysis of the American Heart Association Get With the Guidelines-Stroke Registry and China National Stroke Registry 2016
  • Quality of Ischemic Stroke-related Care in Patients With Chronic Kidney Disease (CKD) on Dialysis: Findings From Get With the Guidelines-stroke 2016
  • Relationship Between Hospital Process Performance and Mortality Among Patients With Acute Ischemic Stroke 2016
  • Substantial Progress yet Significant Opportunity for Improvement in Stroke Care in China 2016
  • Systematic Review of Radiographic and Symptomatic Brain Infarcts in Carotid Artery Interventions. 2016
  • The Association of Chronic Kidney Disease (CKD) With 30-day and 1-year Post Ischemic Stroke Mortality and Rehospitalization: Get With the Guidelines (GWTG) Stroke 2016
  • Use of Intravenous Tissue Plasminogen Activator in Patients Without a Stroke (Stroke Mimics): Findings From the get With the Guidelines Stroke Registry 2016
  • Variation in the Rates of Acute Ischemic Stroke Transfers Between Hospitals in the United States 2016
  • In-hospital Depression and Anxiety and History of Depression Predict 3 Months Post-stroke Depression and Anxiety 2016
  • Women and Minorities Have Lower Patient-reported Functional Status 3 Months Post-stroke 2016
  • Accurate Outcome Predictions for Intracerebral Hemorrhage Patients Are More Likely Than Inaccurate Predictions to Be Influenced by Co-morbidities Not Included in Clinical Scales 2015
  • Clinical Effectiveness of Anticoagulation with Warfarin among Ischemic Stroke Patients with Atrial Fibrillation: Findings from the Patient-Centered Research into Outcomes Stroke Patients Prefer and Effectiveness Research (PROSPER) Study 2015
  • Clinical Effectiveness of Statin Therapy after Ischemic Stroke: Primary Results from the PROSPER Study 2015
  • Depressive Symptoms and Risk of Stroke in African Americans: Findings from the Jackson Heart Study 2015
  • Dose Response Relationship in Transcranial Direct Current Stimulation Stroke Motor Recovery Studies 2015
  • Falls After Intracerebral Hemorrhage 2015
  • Healthcare Resource Availability, Acute Ischemic Stroke Outcomes and Quality of Care 2015
  • High vs. Moderate-intensity Statin Therapy After Ischemic Stroke: Findings from PROSPER 2015
  • Hospital Improvement with Scheduling Stroke Specialty Care Follow-up Appointments 2015
  • Increased Prevalence of Potential Right-to-Left Shunting in Children with Sickle Cell Anemia and Stroke 2015
  • Inpatient Rehabilitation Facility Care Reduces the Likelihood of Death and Rehospitalization After Stroke Compared with Skilled Nursing Facility Care 2015
  • Intraventricular Hemorrhage and Long-term Incontinencea and Dysmobility After Intracerebral Hemorrhage 2015
  • Is Hospital Discharge Day of the Week Associated with Measures of Care Continuity for Stroke Patients? 2015
  • Ischemic Lesions in Intracerebral Hemorrhage Associated with Drop in Blood Pressure and Poor Outcomes in the ERICH Study 2015
  • Race/Ethnic Differences in Microbleed Characteristics and Association of Microbleeds with Poor Outcomes in the ERICH Study 2015
  • Sex-age Interactions and Differences in Outcomes After Intracerebral Hemorrhage 2015
  • Shape of the TPA Time - Benefit Curve: Insights From The National US Get With The Guidelines - Stroke Population 2015
  • The Impact of Contrast Based CTA/CTP Brain Attack Protocol on Kidney Function 2015
  • The Impact of Fever on Presentation in Intracerebral Hemorrhage: The Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH) Study 2015
  • Use of Endovascular Therapy and Trends in Clinical Outcomes within the Nationwide Get With The Guidelines-Stroke Registry 2015
  • Validating the Association of Peripheral Monocyte Count with 30-Day Case-Fatality in Intracerebral Hemorrhage 2015
  • Venous Thromboembolism Complications In Patients With Intracerebral Hemorrhage 2015
  • Temporal Correlation Perfusion Mapping Introduces a Robust and Rapid Method of Identifying Penumbra in Acute Ischemic Stroke 2015
  • Adherence to ECASS III 3-4.5 Hour Exclusion Criteria and Association with Outcome in Clinical Practice: Data from Get With The Guidelines (GWTG)-Stroke 2013
  • Are "Drip and Ship" Patients Different than Other rt-PA Treated Patients? Clinical Characteristics and Patient Outcomes. 2013
  • How Reliably Do Clinicians Predict Stroke Outcomes? Results from the JURaSSiC (Clinician JUdgment vs. Risk Score to predict Stroke outComes) randomized trial. 2013
  • Ischemic Stroke Hospitalization Rates by State and Age 2013
  • No Independent Association Between Extended-Release Niacin (ERN) Therapy and Ischemic Stroke in Patients with Established Cardiovascular Disease: A Detailed Analysis from the AIM HIGH Trial 2013
  • Patient-centered Predictors of Rehabilitation Care after Acute Stroke 2013
  • Predictive Validity of Barthel Index Compared to NIHSS for Discharge Destination Following an Acute Stroke Hospitalization 2013
  • Prehospital Stroke Screen Accuracy in a State with an Emergency Medical Services Protocol for Routing Patients to Acute Stroke Centers 2013
  • Quality of Care and In-Hospital Outcomes by Race and Ethnicity among Patients Hospitalized with Intracerebral Hemorrhage: Findings from 123,623 Patients in the Get With The Guidelines-Stroke Program 2013
  • Time to Treatment with Intravenous Tissue Plasminogen Activator and Outcome from Acute Ischemic Stroke in the National US GWTG-Stroke Population 2013
  • Use of Strategies to Improve Door-to-Needle Times with Tissue Plasminogen Activator in Acute Ischemic Stroke by US Hospitals: Findings from the Target: Stroke Survey 2013
  • Withdrawal of Care in the Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH) Study 2013
  • Symptom Onset to ED Arrival Time Decreases with a Simple Public Education Campaign 2013
  • Aggressive Blood Pressure Control with Clevidipine in Patients with Acute Intracerebral Hemorrhage is Rapid and Well Tolerated: The ACCELERATE Trial 2011
  • Challenges in Assessing Hospital level Stroke Mortality As a Quality Measure: Association of Ischemic, Hemorrhagic or Total Hospital Stroke Mortality Rates 2011
  • Changes in Ischemic Stroke Incidence in the United States Between 1996 and 2006 2011
  • Characteristics, Hospital Factors, and Temporal Trends in Door-to-Needle Times within 60 Minutes for Acute Ischemic Stroke 2011
  • Concurrent Validity of the National Stroke Project Stroke Severity Score 2011
  • Health-Related Quality of Life after Carotid Stenting versus Carotid Endarterectomy: Results from the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST) 2011
  • Hospital Discharge Outcomes in Mild Stroke Patients Not Treated With tPA: Findings from Get With The Guidelines-Stroke 2011
  • Low Yield of Hospital Inpatient Stroke "Codes": Implications for Resource Allocation 2011
  • Predictors of the Use of Dysphagia Screening in Patients with Acute Ischemic Stroke 2011
  • Relationship between Door-to-Needle Times for Tissue Plasminogen Activator and In-Hospital Clinical Outcomes in Acute Ischemic Stroke 2011
  • Representativeness of Get with the Guidelines-Stroke among Fee-for-Service Medicare Beneficiaries with Ischemic Stroke 2011
  • Risk-adjusted 30-day Intracerebral Hemorrhage Mortality Among The Elderly In The United States, 1993-2006 2011
  • Risk-adjusted 30-day Subarachnoid Hemorrhage Mortality Among The Elderly In The United States, 1993-2006 2011
  • Safety of Carotid Stenting and Endarterectomy in Symptomatic and Asymptomatic Patients: Results from the Carotid Revascularization Endarterectomy vs. Stenting Trial (CREST) 2011
  • The Effects of a Stroke Telerehabilitation In-Home Intervention on Function and Disability: Preliminary Results of a Randomized Clinical Trial 2011
  • Differential Impact of Anterior and Posterior White Matter Lesion Progression on Vascular Cognitive Decline 2010
  • Prediction of In-hospital Stroke Mortality Using Data From the Get With the Guidelines-Stroke Registry 2010
  • Risk Standardized 30-day Mortality and 30-day Readmission After Ischemic Stroke by Hospital Referral Region in the United States: 1999-2005 2010
  • Statewide Hospital-Based Stroke Services in North Carolina: Changes Over 10-Years 2010
  • The Prevalence of Anticoagulation With Warfarin and Its Effects on Risk of Stroke and Medical Costs in Medicare Beneficiaries With Atrial Fibrillation 2010
  • Get With the Guidelines-Stroke is Associated with Improved Processes of Care for Hemorrhagic Stroke. 2009
  • Influence of a Pivotal Trial on Hospital-based Assessment of Lipids and Discharge Statin Treatment-Analysis of the GWTG-Stroke Database. 2009
  • The Golden Hour and Acute Brain Ischemia: Presenting Features and Lytic Therapy in Over 30,000 Patients Arriving within 60 Minutes of Onset at GWTG-S Hospitals 2009
  • Timing of Hospital Arrival Among GWTG Stroke Participants 2002-2007: Trends, Variations, and Implications 2009
  • 30-day mortality rates following acute ischemic stroke in the elderly: 1994 to 2003 2008
  • Adherence eValuation after ischemic stroke longitudinal (AVAIL): Identifying facilitators of adherence to stroke prevention medications 2008
  • Atorvastatin is similarly effective in all ischemic stroke subtypes: Secondary analysis of the SPARCL trial 2008
  • Effect of atorvastatin in patients age 65 and over with a recent stroke or transient ischemic attack 2008
  • Increased early stroke-related mortality but not readmission rates in the stroke belt 2008
  • Lack of impact of EMS training and use of the cincinnati prehospital stroke scale 2008
  • Lower antithrombotic medication use among eligible older ischemic stroke patients 2008
  • Association of interleukin-1 beta (IL1B) gene and brain arteriovenous malformation in Caucasians 2007
  • CT angiography in the stroke outcomes and neuroimaging of intracranial atherosclerosis (SONIA) study 2007
  • Cost-effectiveness analysis of usual stroke care vs pharmacological therapy in acute ischemic stroke patients 2007
  • Demographics and treatment modality: Predictors of vasospasm in 201 consecutive patients with aneurysmal subarachnoid hemorrhage 2007
  • Gender differences in morbidity associated with aneurysmal subarachnoid hemorrhage 2007
  • Rapid change in prescribing behavior in hospitals participating in get with the guidelines-stroke after release of the MATCH clinical trial results 2007
  • The excess burden of stroke among adults with homozygous sickle cell disease 2007
  • Thrombolytic usage for acute ischemic stroke as reflected in medicare 2002 and 2004 claims files: Rates and determinants of use 2007
  • Advanced imaging techniques reveal detailed angioarchitecture in cerebral cavernous malformations 2006
  • An examination of patterns of 12-month medicare reimbursements for patients hospitalized with ischemic or hemorrhagic stroke in 1991 vs 2000 2006
  • Impact of length of stay and costs on the ability of hospitals to adopt new technology for the treatment of acute ischemic stroke patients 2006
  • TNF alpha-238G > a promoter polymorphism is associated with increased risk of new hemorrhage in the natural course of patients with brain arteriovenous malformations 2006
  • Amphetamine-enhanced stroke recovery trial: Concurrent validity of the stroke impact scale 2005
  • Amphetamine-enhanced stroke recovery trial: Effect of stroke location and severity on recovery rate and outcome 2005
  • Intraarterial thrombolytic therapy in the postcoronary angiography stroke 2005
  • Peripartum stroke: Incidence, mortality, and outcomes 2005
  • Simvastatin attenuates serum markers of vasospasm after aneurysmal subarachnoid hemorrhage 2005
  • The cost-effectiveness of acute stroke treatments: A comparison of using the subset of patients included in randomized trials versus a more population-based perspective 2005
  • Intraarterial thrombolytic therapy in the postcoronary angiography stroke 2005
  • Validation of the Charlson Index for Ischemic Stroke. 2004
  • Reduced stroke mortality with statin use in the heart and estrogen/progestin replacement study (HERS) 2003
  • VA stroke (VASt) study: Care by neurologists is associated with increased testing but improved outcomes 2003
  • Improved reliability of stroke classification using the TOAST criteria 2001
  • A comparison of primary care physician-reported stroke prevention practices in the United States and United Kingdom. 1997
  • COST-EFFECTIVENESS OF CAROTID ENDARTERECTOMY - A DECISION-MODEL ANALYSIS OF 3 CLINICAL SCENARIOS 1994
  • Pharmacology of recovery after stroke 1990
  • Postischemic synaptic excitation and N-methyl-D-aspartate receptor activation in gerbils 1990
  • TIA WITH BENIGN OUTCOME 1982